Walk Ahead for a Brain Tumor Cure on Oct. 21
Thousands expected at annual event
Event Information (passed)
The ninth annual Walk Ahead for a Brain Tumor Cure is Sunday, Oct. 21, 2018 at Sawyer Point.
- Registration begins at 7:30 a.m.
- Timed 5K run begins at 8:30 a.m.
- 5K walk begins at 9 a.m.
- Wheelchair friendly 2K begins at 9 a.m.
Thousands of walkers and runners will support research and educational efforts of the University of Cincinnati Brain Tumor Center at the University of Cincinnati Gardner Neuroscience Institute.
Now nearly a decade in existence, Walk Ahead 2018 will have raised $2 million over its entire lifetime, following the 2018 event.
Brain tumors are not uncommon. More than 200,000 people are stricken with brain tumors in America every year. During the last two decades, the frequency of brain tumors has increased 22 percent overall and 55 percent in people over 65 years of age. The University of Cincinnati Brain Tumor Center is a regional destination for brain tumor patients, providing compassionate care while striving to find causes and cures. The funds raised through Walk Ahead advance the innovative research necessary to developing new treatments.
Related Stories
UC’s Hoxworth Blood Center, Bearcats team up to tackle need for...
September 6, 2024
Hoxworth Blood Center, University of Cincinnati, is joining forces with the UC Bearcats to address the urgent need for blood donations in the Greater Cincinnati area. This September, the Bearcat family is stepping up to support local patients, and you can be a part of it.
Ways to cope with the emotional side of breast cancer
September 6, 2024
The University of Cincinnati's Barbara Walker was featured in an Everyday Health article discussing ways to cope with the emotional aspect of metastatic triple-negative breast cancer.
Cancer Center researcher studies combination therapy to improve...
September 6, 2024
The University of Cincinnati Cancer Center’s Eric Vick, MD, PhD, has been awarded a nearly $215,000 grant from the Leukemia and Lymphoma Society (LLS) and a $50,000 American Society of Clinical Oncology (ASCO) Young Investigator Award to continue research into a combination therapy treatment for acute myeloid leukemia (AML).